نتایج جستجو برای: abacavir

تعداد نتایج: 949  

2017
Daniel Yerly Yuri Andreiw Pompeu Ryan J. Schutte Klara. K. Eriksson Anette Strhyn Austin. W. Bracey Soren Buus David A. Ostrov

Adverse drug reactions are one of the leading causes of morbidity and mortality in health care worldwide. Human leukocyte antigen (HLA) alleles have been strongly associated with drug hypersensitivities, and the causative drugs have been shown to stimulate specific T cells at the sites of autoimmune destruction. The structural elements recognized by drug-specific T cell receptors (TCRs) in vivo...

Journal: :The Journal of antimicrobial chemotherapy 2008
José A Mira Luis F López-Cortés Pablo Barreiro Cristina Tural Manuel Torres-Tortosa Ignacio de Los Santos Gil Patricia Martín-Rico María J Ríos-Villegas José Juan Hernández-Burruezo Dolores Merino Miguel Angel López-Ruz Antonio Rivero Leopoldo Muñoz Mercedes González-Serrano Antonio Collado Juan Macías Pompeyo Viciana Vincent Soriano Juan A Pineda

OBJECTIVES To compare the response to hepatitis C virus (HCV) therapy among human immunodeficiency virus (HIV)/HCV co-infected patients receiving a nucleos(t)ide reverse transcriptase inhibitor [N(t)RTI] backbone consisting of abacavir plus lamivudine with that observed in subjects who receive tenofovir plus lamivudine or emtricitabine. METHODS A total of 256 subjects, enrolled in a cohort of...

2017
George van den Driessche Denis Fourches

BACKGROUND Human leukocyte antigen (HLA) surface proteins are directly involved in idiosyncratic adverse drug reactions. Herein, we present a structure-based analysis of the common HLA-B*57:01 variant known to be responsible for several HLA-linked adverse effects such as the abacavir hypersensitivity syndrome. METHODS First, we analyzed three X-ray crystal structures involving the HLA-B*57:01...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007
Celia K S Chui Zabrina L Brumme Chanson J Brumme Benita Yip Elizabeth J Phillips Julio S G Montaner P Richard Harrigan

BACKGROUND Abacavir hypersensitivity is strongly associated with the human leukocyte antigen (HLA)-B*5701 allele; however, the cost of routine high-resolution HLA typing before initiation of therapy remains prohibitive. We propose a simple approach to reduce B*5701-associated abacavir hypersensitivity based on the screening of human immunodeficiency virus (HIV) reverse transcriptase (RT) for a ...

Journal: :AIDS 2008
Caroline A Sabin Signe W Worm Rainer Weber Peter Reiss Wafaa El-Sadr Francois Dabis Stephane De Wit Matthew Law Antonella D'Arminio Monforte Nina Friis-Møller Ole Kirk Christian Pradier Ian Weller Andrew N Phillips Jens D Lundgren

BACKGROUND Two nucleos(t)ide reverse transcriptase inhibitors (NRTIs)--abacavir and didanosine--may each be associated with excess risk of myocardial infarction. The reproducibility of this finding in an independent dataset was explored and plausible biological mechanisms were sought. METHODS Biomarkers, ischemic changes on the electrocardiogram, and rates of various predefined types of cardi...

2017
Heawon Ann Ki Hyon Kim Hyun Young Choi Hyun Ha Chang Sang Hoon Han Kye Hyung Kim Jin Soo Lee Yeon Sook Kim Kyung Hwa Park Young Keun Kim Jang Wook Sohn Na Ra Yun Chang Seop Lee Young Wha Choi Yil Seob Lee Shin Woo Kim

BACKGROUND Abacavir is a widely-used nucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus (HIV) infection. Mandatory postmarketing surveillance was conducted in Korea to monitor the safety and evaluate the effectiveness of Ziagen® (abacavir sulfate 300 mg; ViiV Healthcare, Middlesex, UK). MATERIALS AND METHODS An open-label, multi-center, non-interventi...

Journal: :The Journal of pharmacology and experimental therapeutics 2001
S A Thomas A Bye M B Segal

The role of the blood-brain and blood-cerebrospinal fluid (CSF) barriers in the distribution of anti-human immunodeficiency virus (HIV) drugs is integral to the design of effective treatment regimens for HIV infection within the brain. Abacavir (formerly 1592U89) is a nucleoside analog reverse transcriptase inhibitor, which has activity against HIV. The ability of this drug to reach the brain a...

Journal: :journal of the iranian chemical research 0
adnan a. bekhit department of pharmaceutical chemistry, school of pharmacy, addis ababa university, addis ababa1176 ethiopia. adissu alemayehu department of pharmaceutical chemistry, school of pharmacy, addis ababa university, addis ababa1176 ethiopia. abdel-maaboud i. mohamed department of pharmaceutical chemistry, school of pharmacy, addis ababa university, addis ababa1176 ethiopia. ariaya hymete department of pharmaceutical chemistry, school of pharmacy, addis ababa university, addis ababa1176 ethiopia.

a simple, accurate and precise hptlc- densitometry method for the simultaneousdetermination of abacavir, lamivudine and zidovudine in pharmaceutical tablet has beendeveloped. separation of tablet components was performed on aluminum backed hptlc plates(silica gel 60 f254 20×20 cm with 0.2 mm thickness, camag, muttenz, switzerland ) usingmethanol : chloroform : acetonitrile (4 : 8 : 3 v/v). good...

Journal: :Antiviral therapy 2010
Victor Musiime Lindsay Kendall Sabrina Bakeera-Kitaka Wendy B Snowden Florence Odongo Margaret Thomason Philippa Musoke Kimberly Adkison David Burger Peter Mugyenyi Adeodata Kekitiinwa Diana M Gibb A Sarah Walker

BACKGROUND No data on once-daily dosing of nucleoside analogues in African children currently exist. We compared the pharmacokinetics (PK) of once- versus twice-daily lamivudine and abacavir treatment using the World Health Organization recommended weight band dosing of scored adult tablets. METHODS HIV type-1 (HIV-1)-infected Ugandan children aged 3-12 years receiving antiretroviral therapy ...

Journal: :The Brazilian Journal of Infectious Diseases 2016

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید